University of Maryland School of Medicine Researchers Receive NIH Grant to Develop Personalized Medicine Program for Genetic Types of Diabetes

June 18, 2014

Genomic screening will help detect often-misdiagnosed monogenic diabetes, tailor treatments and identify at-risk family members

Toni I. Pollin, M.S., Ph.D., a University of Maryland genetics researcher and lead investigator on the study.

The National Institutes of Health (NIH) has awarded a four-year, $3.7 million grant to researchers at the University of Maryland School of Medicine to develop a personalized medicine program to help doctors diagnose and treat monogenic diabetes – a form of diabetes caused by a mutation in a single gene. The study will evaluate methods to implement this program in various health care settings, with an objective to develop a model that could also be applied to caring for patients with genetic variations of other common diseases.